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REGULATORY AGENCY ACTION

Proposed regulatory action in this area
will be discussed at future meetings.
A consumer pamphlet has been prepared as a joint project by the Board
and the California Optometric Association. However, the Board currently lacks
funding for printing and public distribution of the pamphlet.
FUTURE MEETINGS:
To be announced.

BUREAU OF PERSONNEL
SERVICES
Chief: Jean Orr

(916) 920-6311
The Bureau of Personnel Services,
formerly the Bureau of Employment
Agencies, was established within the
Department of Consumer Affairs to
regulate those businesses which secure
employment or engagements for others
for a fee. The Bureau regulates both
employment agencies and nurses' registries. Those businesses which place
applicants in temporary positions or
positions which command annual gross
salaries in excess of $25,000 are exempt
from Bureau regulation.
The Bureau's primary objective is to
limit abuses among those firms which
place individuals in a variety of employment positions. It prepares and
administers a licensing examination and
issues several types of licenses upon
fulfillment of the Bureau's requirements.
There are approximately 2,100 licensees.
The Bureau is assisted by an Advisory Board created by the Employment
Agency Act. This seven-member Board
consists of three representatives from
the employment agency industry and
four public members. All members are
appointed for a term of four years.
There are currently three vacancies
on the Advisory Board: two industry
positions and one public member
position.
MAJOR PROJECTS:
Impacts of AB 2929. Due to the
deregulation of employer-retained
agencies pursuant to AB 2929 (see
CRLR Vol. 7, No. 1 (Winter 1987) p.
56), the number of Bureau licensees may
be significantly reduced.
Bureau staff and selected Advisory
Board members plan to meet with Marie
Shibuya-Snell, Director of the Department of Consumer Affairs, to discuss
the future of the Bureau. The Department recently sent industry members
information on AB 2929 and also

included a three-page survey. The
survey results indicate that the industry
wants the Bureau to stay in existence.
LEGISLATION:
AB 2733 (Bane), a bill clarifying
which employers are required to pay for
their employees' unemployment insurance, has been chaptered (Chapter 793,
statutes of 1986). Following review by
legal counsel Don Chang, the Bureau
plans to inform nurses' registries and
babysitting and domestic agencies as to
how this legislation affects them.
RECENT MEETINGS:
The Advisory Board met on January
9 in Los Angeles, with discussion focusing on the Board's purpose. Members
commented that they would like more
interaction with Bureau staff in the
form of written recommendations.
There was also some discussion at
the January 9 meeting as to whether
domestics should be deregulated. A
subcommittee was appointed to look
into the matter of deregulation of
employer-retained domestics and will
report back at the next Advisory Board
meeting.
FUTURE MEETINGS:
To be announced.

BOARD OF PHARMACY
Executive Officer: Lorie G. Rice
(916) 445-5014
The Board of Pharmacy grants
licenses and permits to pharmacists,
pharmacies, drug manufacturers, wholesalers and sellers of hypodermic needles.
It regulates all sales of dangerous drugs,
controlled substances and poisons. To
enforce its regulations, the Board
employs full-time inspectors who investigate accusations and complaints
received by the Board. Investigations
may be conducted openly or covertly as
the situation demands.
The Board conducts fact-finding and
disciplinary hearings and is authorized
by law to suspend or revoke licenses or
permits for a variety of reasons, including professional misconduct and
any acts substantially related to the
practice of pharmacy.
The Board consists of ten members,
three of whom are public. The remaining members are pharmacists, five of
whom must be active practitioners. All
are appointed for four-year terms.

MAJOR PROJECTS:
Handbook. A new handbook of
current Pharmacy Laws and Regulations
became available in March 1987. The
Board will also publish a newsletter
discussing, among other topics, the law
regarding the rescheduling of anabolic
steriods as controlled substances.
Mail Order Prescriptions. The
Board has been investigating the mailorder prescription business, which is not
presently allowed in California. The
Board has been studying other states in
which the business is permitted, particularly with respect to deaths, injuries,
or other complaints from consumers
resulting from mail order prescriptions.
The Board has also communicated with
the Federal Trade Commission (FTC)
for information on problems in other
states. An FTC representative is scheduled to appear at a future meeting to
update the Board on an ongoing FTC
study of the mail order prescription
business. The Little Hoover Commission
is also studying this matter.
After receiving and evaluating information from the FTC and the Little
Hoover Commission, the Board will
examine its regulations and determine
whether changes or additions to its
regulatory authority are needed. The
Board will also evaluate various pieces
of proposed legislation dealing with mail
order prescriptions.
Regulations. Section 1769.1 of Title
16 of the California Administrative
Code, which addresses the standards for
reinstatement of licensees, was disapproved by the Office of Administrative Law (OAL). Rather than
resubmit the regulations to OAL, the
Board has decided to publish the standards as guidelines and distribute them to
those seeking reinstatement.
Section 1781.5 of Title 16 dealing
with hearings for exemptees was also
recently disapproved by OAL, and will
be resubmitted with corrections. The
section would permit the Board to issue
an exemption certificate to a manufacturer or wholesaler which employs an
individual who has passed a written
examination given by the Board and is a
pharmacist licensed in a state other than
California, or has at least two years of
applicable experience in the manufacture, wholesale, or distribution of
dangerous drugs.
Finally, the Board's continuing education regulations were also disapproved by OAL, and will be
resubmitted. (See CRLR Vol. 6, No. 4
(Fall 1986) p. 49.)
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